Is cytotoxic chemotherapy for lymphoma currently feasible for patients in Malawi? A debate.
There is currently no systematic provision for chemotherapy of adult patients with cancer in Malawi. Is the introduction of such a service now feasible in Malawi, and should an individual patient with potentially treatable disease be given chemotherapy in the absence of such a service? The technical, economic and moral issues are discussed here in the form of a debate.
Crutchlow
Emma
E
Tiyanjane Clinic, Queen Elizabeth Central Hospital, Blantyre, Malawi. emma.crutchlow@nhs.net
Miombe
Yohannie
Y
Latham
Tom
T
D000328:Adult; D044966:Anti-Retroviral Agents / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000191:economics; D004317:Doxorubicin / Q000008:administration & dosage / Q000191:economics; D016527:Drug Costs; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D015497:HIV-1; D006801:Humans; D016483:Lymphoma, AIDS-Related / Q000188:drug therapy* / Q000191:economics; D008295:Malawi; D011241:Prednisone / Q000008:administration & dosage / Q000191:economics; D014750:Vincristine / Q000008:administration & dosage / Q000191:economics
D044966:Anti-Retroviral Agents; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone